SAN DIEGO: Aethlon Medical, Inc. announced today that the Institutional Review Board (IRB) of the University of California, Irvine (UCI) has approved a multi-indication clinical study entitled, "Plasma Exosome Concentration in Cancer Patients Undergoing Treatment."
- THE EDITORIAL TEAM
- Health Security
- Posted On